Loading...

FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
128005 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128006 500 µg 235€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  2. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  3. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  4. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  5. Zaman R, et al. 2021. Immunity. :. PubMed
  6. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  7. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  8. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  9. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  10. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  11. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  12. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  13. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  14. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  15. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  16. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  17. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  18. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  19. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  20. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  21. Dong L, et al. 2021. Cancer Cell. . PubMed
  22. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  23. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  24. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  25. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  26. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  27. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  28. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  29. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  30. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  31. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  32. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  33. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  34. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  35. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  36. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  37. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  38. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  39. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  40. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  41. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  42. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  43. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  44. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  45. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  46. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  47. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  48. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  49. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  50. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  51. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  52. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  53. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  54. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  55. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  56. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  57. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  58. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  59. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  60. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  61. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  62. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  63. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  64. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  65. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  66. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  67. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  68. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  69. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  70. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  71. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  72. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  73. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  74. He J, et al. 2019. J Clin Invest. 130. PubMed
  75. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  76. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  77. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  78. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  79. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  80. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  81. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  82. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  83. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  84. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  85. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  86. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  87. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  88. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  89. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  90. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  91. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  92. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  93. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  94. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  95. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  96. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  97. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  98. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  99. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  100. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  101. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  102. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  103. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  104. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  105. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  106. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  107. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  108. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  109. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  110. Tang S, et al. 2022. Virol J. 19:32. PubMed
  111. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  112. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  113. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  114. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  115. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  116. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  117. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  118. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  119. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  120. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  121. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  122. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  123. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  124. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  125. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  126. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  127. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  128. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  129. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  130. Jones GS, et al. 2020. mSphere. 5:. PubMed
  131. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  132. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  133. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  134. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  135. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  136. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  137. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  138. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  139. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  140. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186135 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12.09.2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Pacific Blue™ anti-mouse Ly-6C

  • APC anti-mouse Ly-6C

  • Purified anti-mouse Ly-6C

  • Biotin anti-mouse Ly-6C

  • FITC anti-mouse Ly-6C

  • Alexa Fluor® 647 anti-mouse Ly-6C

  • PE anti-mouse Ly-6C

  • PerCP/Cyanine5.5 anti-mouse Ly-6C

  • PE/Cyanine7 anti-mouse Ly-6C

  • Alexa Fluor® 488 anti-mouse Ly-6C

  • Alexa Fluor® 700 anti-mouse Ly-6C

  • APC/Cyanine7 anti-mouse Ly-6C

  • PerCP anti-mouse Ly-6C

  • Brilliant Violet 570™ anti-mouse Ly-6C

  • Brilliant Violet 421™ anti-mouse Ly-6C

  • Brilliant Violet 510™ anti-mouse Ly-6C

  • Brilliant Violet 605™ anti-mouse Ly-6C

  • Brilliant Violet 711™ anti-mouse Ly-6C

  • Purified anti-mouse Ly-6C (Maxpar® Ready)

  • Brilliant Violet 785™ anti-mouse Ly-6C

  • PE/Dazzle™ 594 anti-mouse Ly-6C

  • APC/Fire™ 750 anti-mouse Ly-6C

  • TotalSeq™-A0013 anti-mouse Ly-6C

  • Brilliant Violet 650™ anti-mouse Ly-6C

  • TotalSeq™-C0013 anti-mouse Ly-6C

  • TotalSeq™-B0013 anti-mouse Ly-6C

  • APC/Fire™ 810 anti-mouse Ly-6C Antibody
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account